The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Zoth Lota S. | Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Hastings Paul J | Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Heffernan Michael Thomas | Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Joustra Wouter | Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Astley-Sparke Philip | Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Brunk Gerald A | Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Glickman Richard M | Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Grossman William | Interim Chief Medical Officer, Director | Grant(A) | 31K | — | $0 |
| Jun 16, 2026 | Grossman William | Interim Chief Medical Officer, Director | Grant(A) | 200K | — | $0 |
| Jan 30, 2026 | Buck Jill | Chief Development Officer | Grant(A) | 195K | — | $0 |
| Jan 30, 2026 | Boyd Matthew Ross | Chief Regulatory Officer | Grant(A) | 195K | — | $0 |
| Jan 30, 2026 | Connolly Joan | Chief Technology Officer | Grant(A) | 195K | — | $0 |
| Jan 30, 2026 | Cooper Ronald Harold Wilfred | CEO & President, Director | Grant(A) | 801K | — | $0 |
| Jan 30, 2026 | Daws D. Ryan | Chief Financial Officer | Grant(A) | 220K | — | $0 |
| Jan 30, 2026 | Nichols Alexander Julian | Chief Strategy & Ops. Ofc | Grant(A) | 195K | — | $0 |
| Jan 30, 2026 | Giguere Lee | Chief Legal Ofc. and Corp Secy | Grant(A) | 195K | — | $0 |
| Jan 30, 2026 | Cheung Anthony Tzeyew | Chief Scientific Officer | Grant(A) | 195K | — | $0 |
| Sep 30, 2025 | Sweiti Hussein | Chief Medical Officer | Grant(A) | 600K | — | $0 |
| Jul 8, 2025 | Buck Jill | Chief Development Officer | Grant(A) | 100K | — | $0 |
| Jul 8, 2025 | Grossman William | Director | Grant(A) | 45K | — | $0 |
| Jul 8, 2025 | Heffernan Michael Thomas | Director | Grant(A) | 45K | — | $0 |
| Jul 8, 2025 | Astley-Sparke Philip | Director | Grant(A) | 45K | — | $0 |
| Jul 8, 2025 | Boyd Matthew Ross | Chief Regulatory Officer | Grant(A) | 100K | — | $0 |
| Jun 16, 2025 | Bos Jasper | Director | Grant(A) | 23K | — | $0 |
| Jun 16, 2025 | Brunk Gerald A | Director | Grant(A) | 23K | — | $0 |
| Jun 16, 2025 | Glickman Richard M | Director | Grant(A) | 23K | — | $0 |
| Jun 16, 2025 | Hastings Paul J | Director | Grant(A) | 23K | — | $0 |
| Jun 16, 2025 | Joustra Wouter | Director | Grant(A) | 23K | — | $0 |
| Jun 16, 2025 | Pott Amy | Chief Global Comm. Ofc. | Grant(A) | 400K | — | $0 |
| Jun 16, 2025 | Zoth Lota S. | Director | Grant(A) | 23K | — | $0 |
| Jan 29, 2025 | Cooper Ronald Harold Wilfred | CEO & President, Director | Grant(A) | 850K | — | $0 |
| Jan 29, 2025 | Cheung Anthony Tzeyew | Chief Scientific Officer | Grant(A) | 250K | — | $0 |
| Jan 29, 2025 | Daws D. Ryan | Chief Financial Officer | Grant(A) | 280K | — | $0 |
| Jan 29, 2025 | Giguere Lee | Chief Legal Ofc. and Corp Secy | Grant(A) | 250K | — | $0 |
| Jan 29, 2025 | Nichols Alexander Julian | Chief Strategy & Ops. Ofc | Grant(A) | 250K | — | $0 |
| Jan 29, 2025 | Pruthi Raj Som | Chief Medical Officer | Grant(A) | 280K | — | $0 |
| Oct 30, 2024 | Forbion Growth Management B.V. | 10% Owner | Buy(P) | 562K | $8.90 | $5.0M |
| Oct 21, 2024 | Connolly Joan | Chief Technology Officer | Grant(A) | 210K | — | $0 |
| Oct 21, 2024 | Cheung Anthony Tzeyew | Chief Scientific Officer | Grant(A) | 100K | — | $0 |
| Oct 8, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 800 | $6.60 | $5K |
| Oct 7, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 12K | $6.55 | $78K |
| Oct 4, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 6K | $6.54 | $39K |
| Oct 3, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 6K | $6.48 | $37K |
| Oct 2, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 10K | $6.37 | $65K |
| Oct 1, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 35K | $6.44 | $227K |
| Sep 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 341K | $6.34 | $2.2M |
| Sep 27, 2024 | Cooper Ronald Harold Wilfred | Chief Executive Officer, Director | Buy(P) | 10K | $5.70 | $57K |
| Sep 27, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 38K | $5.94 | $228K |
| Sep 27, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 3K | $6.38 | $21K |
| Jul 24, 2024 | Pruthi Raj Som | Chief Medical Officer | Grant(A) | 110K | — | $0 |
| Jul 22, 2024 | Cooper Ronald Harold Wilfred | Chief Executive Officer, Director | Grant(A) | 1.3M | — | $0 |
| Jun 15, 2024 | Brunk Gerald A | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2024 | Bos Jasper | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2024 | Glickman Richard M | Director | Grant(A) | 20K | — | $0 |
| Jun 15, 2024 | Joustra Wouter | Director | Grant(A) | 40K | — | $0 |
| Jun 15, 2024 | Hastings Paul J | Director | Grant(A) | 40K | — | $0 |
| Jun 15, 2024 | Zoth Lota S. | Director | Grant(A) | 20K | — | $0 |
| May 28, 2024 | Glickman Richard M | Director | Option exercise(M) | 120 | $0.89 | $107 |
| May 28, 2024 | Glickman Richard M | Director | Option exercise(M) | 120 | — | $0 |
| Apr 22, 2024 | Fonds De Solidarite Des Travailleurs Du Quebec | 10% Owner | Sell(S) | 48K | $15.00 | $718K |
| Apr 19, 2024 | Fonds De Solidarite Des Travailleurs Du Quebec | 10% Owner | Sell(S) | 100 | $15.00 | $2K |
| Apr 18, 2024 | Fonds De Solidarite Des Travailleurs Du Quebec | 10% Owner | Sell(S) | 5K | $15.01 | $69K |
| Mar 21, 2024 | Zoth Lota S. | Director | Grant(A) | 40K | — | $0 |
| Mar 18, 2024 | Cheung Anthony Tzeyew | Chief Technology Officer | Option exercise(M) | 53K | $0.89 | $47K |
| Mar 18, 2024 | Cheung Anthony Tzeyew | Chief Technology Officer | Option exercise(M) | 53K | — | $0 |
| Mar 15, 2024 | Giguere Lee | Chief Legal Ofc. and Corp Secy | Grant(A) | 225K | — | $0 |
| Feb 20, 2024 | Lumira Capital Investment Management Inc. | 10% Owner | Grant(A) | 155K | $10.00 | $1.6M |
| Feb 20, 2024 | Lumira Capital Investment Management Inc. | 10% Owner | Grant(A) | 645K | $10.00 | $6.4M |
| Feb 20, 2024 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 645K | $10.00 | $6.4M |
| Feb 20, 2024 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 155K | $10.00 | $1.6M |
| Dec 29, 2023 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 400 | $8.30 | $3K |
| Dec 29, 2023 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 10K | $9.09 | $87K |
| Dec 28, 2023 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 5K | $7.69 | $39K |
| Dec 27, 2023 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy(P) | 3K | $7.17 | $20K |
| Nov 30, 2023 | Daws D. Ryan | Chief Financial Officer | Grant(A) | 232K | — | $0 |
| Nov 30, 2023 | Bryce Richard Paul | Chief Medical Officer | Grant(A) | 153K | — | $0 |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 153K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 1.1M | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 1.3M | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 84K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 349K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 45K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 115K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 146K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 9K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 38K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 4K | — | — |
| Oct 31, 2023 | Brunk Gerald A | Director, 10% Owner | Grant(A) | 21K | — | — |
| Oct 31, 2023 | Glickman Richard M | Director | Grant(A) | 25K | — | — |
| Oct 31, 2023 | Cheung Anthony Tzeyew | Chief Technology Officer | Grant(A) | 50K | — | — |
| Oct 31, 2023 | Forbion Growth Sponsor FEAC I B.V. | 10% Owner | Other(J) | 2.3M | — | — |
| Oct 31, 2023 | Forbion Growth Sponsor FEAC I B.V. | 10% Owner | Other(J) | 130K | — | — |
| Oct 31, 2023 | Forbion Growth Sponsor FEAC I B.V. | 10% Owner | Other(J) | 55K | — | — |
| Oct 31, 2023 | Forbion Growth Sponsor FEAC I B.V. | 10% Owner | Other(J) | 950K | — | — |
| Jul 7, 2023 | Sullivan James Crowley | Chief Scientific Officer | Grant(A) | 119K | — | — |
| Jul 7, 2023 | Hanson Jason David | Chief Executive Officer, Director | Grant(A) | 513K | — | — |
| Jul 7, 2023 | Cheung Anthony Tzeyew | Chief Technology Officer | Grant(A) | 185K | — | — |
| Jul 7, 2023 | Nichols Alexander Julian | Pres. & Chief Operating Ofc. | Grant(A) | 102K | — | — |
| Feb 18, 2023 | Nichols Alexander Julian | Pres. & Chief Operating Ofc. | Grant(A) | 178K | — | — |
| Mar 18, 2022 | Sullivan James Crowley | Chief Scientific Officer | Grant(A) | 89K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).